Respiratory effects, nausea, somnolence, and pruritus were compared during a 48-hr period of continuous epidural morphine (n = 34) and fentanyl (n = 32) 3, 6, 12, 24, 36, and 48 
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The side effects of epidural opioids are considered to be related to their rostral spread in the cerebrospinal fluid to supraspinai structures. 1-3 The elimination half-life of morphine, a hydrophilic opioid, is approximately four hours in both cerebrospinal fluid and plasma compartments. ~ However, the concentration attained in the cerebrospinal fluid following epidural injection is far in excess, in the second order, of that in plasma, and a high concentration of morphine is present even up to 24 hr later. 1 Fentanyl, on the other hand, is very lipid soluble. Access of fentanyl to the spinal fluid is more rapid, but so is its uptake by the spinal veins, which results in less free drug in the CSF to migrate rostrally. Plasma concentrations of fentanyl have been shown to increase rapidly following epidural injection. 4'5 Thus, the onset of analgesia is rapid, its duration is shorter, and the incidence of centrally mediated side effects may be reduced. 6-9 During continuous epidural infusion, the rostral spread of these opioids is expected to be less than that following bolus injection since the cerebrospinal fluid concentrations in the vicinity of the site of infusion are expected to be lower. However, a comparative incidence has not been reported.
This study compared the side effects of epidural morphine and fentanyl. For this purpose, respiratory effects, nausea and vomiting, somnolence, and pruritus during continuous epidural infusion of morphine or fentanyl for postoperative pain relief were studied in 68 patients undergoing elective total replacement of the hip or knee joints.
Methods
Sixty-eight patients were studied. Institutionally approved informed consent was obtained from each patient. Patients with abnormal blood coagulation or bleeding time, patients with mental confusion, psychiatric diseases, and alcohol or drug abuse were excluded from the study. Patients were randomly assigned to either the morphine or fentanyl group.
Premedication was not given. Patients were sedated with midazolam, 1-2 rag, as needed in the holding area. A lumbar epidural catheter was inserted at L2. 3 or L3. 4 interspace and was advanced 3 cm cephalad. A bolus of lidocaine 1.5 % with epinephrine, 5 to 10 ml, was injected through the catheter. The catheter was considered to be in the epidural space when the patient felt a warm sensation and/or numbness in both lower extremities. Anaesthesia was induced with thiopentone 2 to 5 mg. kg -I and tracheal intubation was facilitated by succinylcholine. An indwelling catheter was inserted into the bladder. Anaesthesia was maintained with isoflurane and nitrous oxide, supplemented by fentanyl as needed.
Administration of bolus doses and initial adjustment of infusion rate were managed by one of the investigators in all study cases. Initial bolus doses of morphine, Duramorph | (Elkins-Sinn, Inc., Cherry Hill, NJ), were 1,000 to 4,000 ixg in a concentration of 1,000 i~g-ml -~, and initial infusion rates were 100 to 350 tug" hr -t in a concentration of 200 txg 9 ml -I. Initial doses of fentanyl were 40 to 100 I.Lg in the concentration of 10 I~g" ml -I, and initial infusion rates were 20 to 80 I~g' hr -I in the same concentration. The solution was prepared in preservativefree normal saline in a standard intravenous bag and was infused by a Life Care | pump-micro model (Abbott Laboratories, North Chicago, IL). Pain was assessed by a visual analogue scale (VAS) consisting of a lO-cm line marked "no pain" at one end and "worst possible pain" at the other, l~ The patient marked the line according to the pain perceived at the time of examination. The result was expressed as a unitless number ranging from 0 to 100. A bolus injection was repeated as needed in increments of I to 2 ml, and the infusion rate was adjusted to obtain VAS pain scores of between 10 and 30 over a period of up to several hours. Patients were then instructed to call the evaluators whenever the pain or side effects were annoying. The infusion rate was adjusted by 0.5 to 1.0 ml. hr -1 at a time for subsequent complaints of pain (VAS score > 30). Evaluators and patients were blinded with respect to the identity of the opioid.
Respiratory effects were assessed by arterial blood gas analysis and respiratory rate. Nausea,~ l somnolence,~ ~ and pruritus 12 were assessed by VAS. The worst nausea was defined to be present when there was retching or vomiting and the worst pruritus when it was unbearable to the point that patients preferred pain. The worst somnolence was defined to be present when patients could hardly keep their eyes open.
The first assessment of the variables was made at the time of the preoperative visit. The assessment was repeated 3, 6, 12, 24, 36, and 48 hr after the start of the epidural injection. The epidural infusion was discontinued at 48 hr, and the final assessment was made at 72 hr. Nausea was assessed at the time of complaint, since it tended to wane following vomiting or retching. The highest value was used as the score for the nearest time period. In the absence of complaints, VAS score for nausea was assessed at predetermined time periods.
The decision to treat side effects was made by the evaluators based on the assessment of degrees of pain and side effects. The infusion rate was changed in decrements of 0.5 to 1.0 ml. hr -l when the patient was pain-free or the pain was minimal. Patients with PaCO 2 above 50 mmHg and respiratory rate below 10 min -1 were observed closely. Further increase in PaCO 2, together with further progression of somnolence and decline in respiratory rate, was defined to be an indication for naloxone treatment, and the patient was considered to be in respiratory failure. Respiratory failure and very severe pruritus were treated with intravenous infusion of naloxone 100 to 200 I~g" hr -l. Severe nausea was treated with metoclopramide 5 to 10 mg iv.
Differences between the groups and changes over time in VAS scores for pain and for each side effect were tested by analysis of variance for repeated measures design with the naloxone treatment as a time-varying covariate. The data were further tested where appropriate by Bonferroni simultaneous confidence intervals for differences and changes. Side effects were arbitrarily considered to be present when the VAS score was above 30. Incidences of side effects thus defined were tested by Koch's method for the analysis of categorical data for repeated measurement. 13 Since there were only 68 patients in the study, analysis was performed between two time periods. The 72 hr VAS scores were tested by the unpaired Student's t test. The cumulative incidence of patients who developed side effects was tested by Chi-square test for each side effect at all time periods. All incidences at 72 hr were tested by Chi-square test.
Results
The epidural space could not be located in two of the 68 patients. Of the remaining 66, 34 (14 men and 20 women) received epidural morphine and 32 (16 men and 16 women) received epidural fentanyl. There were no differences in age, height, or weight between the groups (Table) . The mean bolus dose and epidural infusion rate were 3,900 _-Z-1,300 Ixg (range, 1,000-6,000 Ixg) and 427 -213 I~g" hr -I (range, 100--800 lxg" hr -I) for morphine and 85 ---46 ~g (range 40-230 Ixg) and 56 ---27 I~g" hr -1 (range 20-120 I~g" h r-l) for fentanyl, respectively. The bolus doses and infusion rates were inversely related to age (bolus dose, R = -0.63, P < 0.001 for morphine and R = -0.54, P < 0.01 for fentanyl; and infusion rate, R = -0.37, P < 0.05 for morphine and R = -0.47, P < 0.01 for fentanyl). Twenty-eight of these patients had a history of hypertension, eight had coronary heart disease, 12 had chronic obstructive lung disease, nine had diabetes 16 16 mellitus, and three had a history of cerebrovascular accidents. Thirty-five patients had total replacement of the hip joint and 31 had unilateral or bilateral total replacement of the knee joint. There was no difference in the intraoperative fentanyl dose between the groups (morphine group 245 _+ 95 ~g and fentanyl group 255 ___ 105 ~g). Four patients in the morphine group were treated with continuous intravenous infusion of naloxone to combat respiratory depression in two and severe generalized pruritus in the other two. Naloxone treatment was a covariate in the analysis of VAS scores for pruritus (P < 0.02) but not for pain, nausea, somnolence, or respiratory variables.
Pain relief was similar in both groups (Figure 1 ). There was no group-time interaction, group effect, or time effect in the scores. All except two patients who were treated with naloxone infusion for pruritus rated the epidural method as satisfactory.
There was a group-time interaction for PaCO 2 (P < 0.001) and a time effect for respiratory frequency (P < 0.001). The PaCO 2 increased in the morphine group and the values for the 3rd, 6th, and 12th hr were higher than the preoperative values (P < 0.02), but PaCO 2 did not change in the fentanyl group (Figure 2) . The decrease in respiratory frequency was significant only at three hours in both groups (P < 0.025). Respiratory depression developed in two patients in the morphine group. Hypercarbia (PaCO 2, 59 mmHg) associated with drowsiness at three hours in one of these patients was treated with a continuous infusion of naloxone. Hypercarbia in the other patient progressed from 51 mmHg at three hours to 60 mmHg, together with the development of marked drowsiness despite naloxone infusion, 100 ~g. hr -I. This patient responded to the increase in the infusion rate to 200 I-~g" hr-1. The naloxone infusion was terminated in both patients the following morning.
There were group-time interactions in the nausea scores (P < 0.05). Nausea developed over the period of 12 hr in the morphine group, but nausea in the fentanyl group had occurred mostly by three hours (Figure 3) . Subsequently, the score and incidence decreased and remained at values no different from the preoperative levels. The score and incidence were both higher in the morphine group at six hours. The cumulative incidence at the 12th and 24th hr was higher in the morphine group (53% vs 28%, P < 0.05, respectively) ( Figure 4 ). Eleven of 16 in the morphine group and three of nine in the fentanyl group were treated with metoclopramide. There was a time effect in the somnolence scores (P < 0.001). There was also a group-time interaction in the analysis of the 24--48 hr incidence (P < 0.01). Somnolence was equally prominent in both groups within several hours. By 24 hr, it was moderate and most patients were readily communicable (Figure 3) . Somnolence continued to improve further in the morphine group, but it remained unchanged at 24 hr level in the fentanyl group. Somnolence was less in the morphine group at 48 hr (P < 0.05).
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There were group as well as time effects in the pruritus scores (P < 0.001). There was a quadratic increase in the scores, and pruritus was the only major subjective complaint during the second day. The score and incidence were higher in the morphine group (Figures 3 and 4) . Two patients in the morphine group required naloxone infusion for treatment. Six patients continued to have pruritus 24 hr after cessation of epidural morphine. There were also group-time interactions in analyses of the preoperative, three and six hour incidences (P < 0.01). The initial increase in the incidence at three hours in the fentanyl group (P < 0.01) was followed by a decline to the preoperative level at six hours. The incidence then gradually increased during the continuous infusion.
The location of pruritus was recorded in 19 out of 21 patients in the morphine group and 10 out of 17 patients in the fentanyl group. In the morphine group, 15 patients noted it first in the face or nose, which became generalized in 13. In the remaining four patients, it was patchy, sparing the face, and was usually localized to the upper arms, chest, or trunk. In addition, mild pruritus in the tape site on the back occurred frequently. In the fentanyl group, pruritus was segmental in seven of ten patients and spared the face. Five in the morphine group and four in the fentanyl group noted either absence of pruritus or, if present, markedly less intense pruritus in the extremities on which operations had been performed. One patient developed an extreme hypersensitivity to touch in both lower extremities that elicited agonizing pain.
A brief visual hallucination was observed in one patient several hours after epidural morphine. Hypotension developed in an 86-yr-old woman following three boluses (total 40 Ixg) of epidural fentanyl. The patient required dopamine infusion at the rate of 5 ~g. kg -I-rain -I for maintenance of blood pressure for approximately four hours. Bowel sounds were detectable by the second day of infusion in all but one patient in the fentanyl group.
Most patients ambulated on the second postoperative day. The duration of postoperative hospitalization was 7.4 _ 1.3 days (range, 5-12 days). Minor postoperative complications developed in seven patients: urinary tract infection in three, pulmonary atelectasis in one, deep vein phlebitis in one, ileus in one, and wound erythema in one. All the complications resolved without further treatment.
Discussion
In this study, both morphine and fentanyl provided adequate and steady postoperative pain relief during a 48-hr period of continuous epidural infusion; pain relief was similar in both groups. However, the severity and pattern of side effects differed between groups as well as among the side effects. Respiratory effects and nausea could be observed for more than 12 hr in the morphine group, whereas changes were less severe and confined to the first few hours in the fentanyl group. Somnolence was an equally prominent side effect in both groups within several hours. By 24 hr, somnolence was less in both groups and was not of clinical significance. However, while it remained at this level in the fentanyl group, it decreased further in the morphine group. Pruritus continued to increase into the second 24-hr period. It was more severe and tended to be generalized in the morphine group but was segmental in the fentanyl group.
The cerebrospinal fluid pharmacokinetic behaviour of morphine predicts that the effects of epidural morphine on the brainstem should be demonstrable as late as 24 hr after a bolus injection. 1'14q6 The pharmacokinetics of epidural fentanyl in the cerebrospinal fluid suggests that rostral spread of fentanyl may occur after lumbar injection, but that concentrations high enough to produce clinical effects may not be sustained at the brainstem level, t7 Epidural fentanyl, though shown to decrease ventilatory response to carbon dioxide, is not associated with PaCO 2 elevation. 22'23 During continuous epidural infusion, plasma fentanyl concentrations have been shown to reach the levels above the lower limit of the threshold concentration, but alveolar ventilation is usually not affected, 8'19'2~ unless larger doses were used. 21 These reports suggest also that significant rostral migration of fentanyl had not occurred following a bolus injection and during the continuous infusion into the epidural space. The patterns of respiratory effects and nausea observed in our patients were similar to those that follow a bolus epidural injection of morphine and fentanyl, respectively. The differences in severity, incidence, and temporal course between the groups were consistent with those expected from differences in the cerebrospinal fluid pharmacokinetics of the respective opioids. The subsequent incidence of the side effects was minimal in both groups, suggesting that brainstem concentrations high enough to cause respiratory depression or nausea were not attained during the continuous infusion of either fentanyl or morphine.
Somnolence has been described following epidural injection of morphine 22'23 as well as fentanyl. 8 '24 In this study, somnolence was the most frequent side effect among those studied, occurring in approximately two thirds of patients in both groups within several hours of treatment. The temporal course of somnolence in the morphine group, i.e., subsequent continued improvement, appears to be consistent with that expected from the pharmacokinetic behavior of an initial bolus dose of morphine in the cerebrospinal fluid. On the other hand, approximately half of the patients in the fentanyl group continued to have somnolence during the entire second 24-hr period. The electroencephalographic pattern that follows intravenous fentanyl 2 ixg. kg -j is comparable to the state of reduced mental vigilance in man, just below the state of light sleep for up to 90 min. 25 In 1985, Ahuja and Strunin reported that plasma fentanyl concentrations during the continuous epidural infusion were 0.4 ng. ml -I at 6 hr and 0.6 ng. m1-1 at 18 hr with an infusion rate of 1 I.Lg" kg -l" hr. 2~ Renaud et al. reported the values of 1 ng. m1-1 and 1.5 ng-ml -I at similar time periods.t9 Plasma concentrations that build up during continuous infusion may account for the slow decline in the measures of somnolence and its persistence during the second day in the fentanyl group.
The mechanism of epidural opioid-induced pruritus is not known. Ballantine et al. advanced an hypothesis that pruritus may be a manifestation of opioid-mediated facilitation of protective reflexes. 26 Opioids suppress noxiously induced reflexes but also excite neurons that do not receive a nociceptive impulse. 27 Following an initial reflex withdrawal, protective reflexes result in hyperalgesia or pruritus in the vicinity of the injury. This hyperalgesia is an antipruritic state, and such attenuation is clearly shown to be mediated at the spinal cord level. 28 '29 In our patients, pruritus persisted in the second 24-hr period while pain relief was adequate and other side effects were declining or had declined. Pruritus was absent in the extremity on which operation was performed and the distribution of pruritus was clearly segmental in the fentanyl group, suggesting that events occurring at the spinal cord are also important in the pathogenesis of pruritus.
Since the majority of our patients were elderly and sedentary, we were cautious with the doses of opioids. However, two elderly patients developed respiratory failure requiring naloxone treatment. In this study, fixed doses were not used. Although the bolus and infusion doses needed to obtain pain relief were inversely related to age in both groups, there was a wide scatter around the regression lines. Fixed doses, even if age-adjusted, would have resulted in a substantial number of patients with inadequate pain relief or marked side effects. In addition, the investigator managing the initial boluses and infusion of narcotics was not blinded and, since equivolumetric doses of morphine and fentanyl were not used, evaluators may not have been blinded during subsequent observations. This could have produced a potential bias in the results. The effects of residual anaesthesia also may have influenced side effects in the early stage of epidural opioids. Thus, the true incidence as well as intensity of early side effects may be different from those observed in this study.
However, the temporal course of respiratory effects and nausea in our patients was similar to that which occurred in volunteers following a bolus injection.14'18 Hypotension that developed in one patient occurred in the immediate postoperative period. Bowel sounds had returned by the second day in all but one patient. During the second day of continuous infusion, the only side effect of clinical concern was pruritus, notably in the morphine group. The side effects were generally less in the fentanyl group with the exception of moderate somnolence that persisted on the second day of infusion. The continuous epidural infusion of opioids, after the initial bolus-related side effects, appears to be a safe technique to provide prolonged and steady pain relief with minimal side effects.
